Fukutin-related protein (FKRP) is a glycosyltransferase involved in the functional glycosylation of α-dystroglycan (DG), a key component in the link between the cytoskeleton and the extracellular matrix (ECM). Mutations in FKRP lead to dystroglycanopathies with broad severity, including limb-girdle and congenital muscular dystrophy. Studies over the past 5 years have elucidated the function of FKRP, which has expanded the number of therapeutic opportunities for patients carrying FKRP mutations. These include small molecules, gene delivery, and cell therapy. Here we summarize recent findings on the function of FKRP and describe available models for studying diseases and testing therapeutics. Lastly, we highlight preclinical studies that hold potential for the treatment of FKRP-associated dystroglycanopathies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657196 | PMC |
| http://dx.doi.org/10.1016/j.tcb.2020.11.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prospective observational study of FKRP-related limb-girdle muscular dystrophy R9: A GRASP consortium study.
Ann Clin Transl Neurol
December 2024
Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA.
Objective: Limb-girdle muscular dystrophy R9 (LGMDR9, formerly known as LGMD2I), caused by variants in the fukutin-related protein (FKRP) gene leads to progressive muscle weakness of the shoulder and pelvic limb-girdles and loss of motor function over time. Clinical management and future trial design are improved by determining which standardized clinical outcome assessments (COA) of function are most appropriate to capture disease presentation and progression, informing endpoint selection and enrollment criteria. The purpose of our study was to evaluate the cross-sectional validity and reliability of clinical outcome assessments in patients with FKRP-related LGMDR9 participating in the Genetic Resolution and Assessments Solving Phenotypes in LGMD (GRASP) natural history study.
View Article and Find Full Text PDFMolecular Study of the Fukutin-Related Protein () Gene in Patients from Southern Italy with Duchenne/Becker-like Phenotype.
Int J Mol Sci
September 2024
Institute for Biomedical Research and Innovation, National Research Council, 87050 Mangone, Italy.
Article Synopsis
- Pathogenic variants in the FKRP gene cause various muscular dystrophies, including Limb-Girdle Muscular Dystrophy type 9 (LGMDR9), which is notably prevalent in Italy.
- A study analyzed 153 patients from Southern Italy showing Duchenne/Becker-like symptoms, identifying pathogenic variants in 16 individuals, with specific variants frequently found.
- The findings emphasize the need to include LGMDR9 in the diagnosis of dystrophinopathies, aiming to improve the identification and management of affected patients in Calabria.
Clinical and genetic evaluation of hereditary myopathies in an adult Saudi cohort.
BMC Neurol
September 2024
Department of Internal Medicine, College of Medicine, King Saud University, PO Box 7805, Riyadh, 11472, Saudi Arabia.
Article Synopsis
- * Out of 87 patients, limb-girdle muscular dystrophy (LGMD) was the most common diagnosis, with 68% of tested patients achieving a genetic diagnosis, primarily identifying dysferlinopathy and FKRP-related disorders.
- * The study emphasizes the importance of various molecular genetic testing methods, particularly noting their success rates, and advocates for better access to advanced testing for conditions like FSHD and mitochondrial myopathies.
Oral ribose supplementation in dystroglycanopathy: A single case study.
JIMD Rep
May 2024
Department of Neurology Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center Nijmegen The Netherlands.
Article Synopsis
- Three types of muscular dystrophy, called dystroglycanopathies, are linked to problems in the ribitol pathway and involve specific gene mutations.
- Ribose supplementation was tested in a patient with limb girdle muscular dystrophy type 2I, showing it was well tolerated and led to significant increases in a beneficial compound (CDP-ribitol) and a decrease in muscle enzyme levels.
- Although the clinical and patient-reported outcomes didn't show objective improvements, the patient felt subjective benefits in muscle strength, fatigue, and pain, suggesting more research is needed on ribose's effects.
Enhanced Diaphragm Muscle Function upon Satellite Cell Transplantation in Dystrophic Mice.
Int J Mol Sci
February 2024
Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
The diaphragm muscle is essential for breathing, and its dysfunctions can be fatal. Many disorders affect the diaphragm, including muscular dystrophies. Despite the clinical relevance of targeting the diaphragm, there have been few studies evaluating diaphragm function following a given experimental treatment, with most of these involving anti-inflammatory drugs or gene therapy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!